Effects of the Knowledge and Attitude Development Program to Promote Preventive Behaviors for Prescription Drug Misuse among High School Students in Central Thailand: A Quasi-Experimental Study
Abstract
Objective: Prescription drug misuse (PDM) among adolescents is an increasing public health issue, leading to significant physical, psychological, and social consequences. There is a pressing need for preventive strategies targeting young people to address this growing concern in Thailand.
Material and Methods: A quasi-experimental study using a repeated-measure design with 2 groups aimed to evaluate the effect of a knowledge and attitude development program on promoting preventive behaviors related to PDM. This study recruited 102 high school students, aged between 16 and 18, enrolled at a school in Central Thailand. The students were divided into 2 groups using multi-stage sampling: the intervention group (n=51) participated in a 4-week knowledge and attitude development program, while the control group (n=51) received a health education booklet. Assessments were conducted through structured questionnaires at 3 points: baseline, post-intervention, and 3-month follow-up. Data analysis was performed using descriptive statistics and a repeated measures analysis of variance.
Results: Significant differences were found in the mean scores of knowledge (F=142.166, p-value<0.001), attitudes (F=219.680, p-value<0.001), and preventive behaviors related to PDM (F=68.871, p-value<0.001) between the intervention and control groups at the 3-month follow-up. Furthermore, the mean scores of all outcomes in the intervention group significantly increased at post-intervention and 3-month follow-up (p-value<0.001). However, no significant improvement was observed in the control group across all time points (p-value>0.05).
Conclusion: The intervention group demonstrated significantly better knowledge, attitudes, and preventive behaviors on PDM than the control group. These findings indicate that the program might support efforts to promote preventive behaviors, and healthcare personnel can consider using it in the planning and management of PDM prevention.
Keywords
Full Text:
PDFReferences
Schepis TS, Teter CJ, McCabe SE. Prescription drug use, misuse, and related substance use disorder symptoms vary by educational status and attainment in U.S. adolescents and young adults. Drug Alcohol Depend 2018;189:172-7.
Schepis TS, Klare DL, Ford JA, McCabe SE. Prescription drug misuse: taking a lifespan perspective. Subst Abuse 2020; 14:1178221820909352.
Schepis TS, Wilens TE, McCabe SE. Prescription drug misuse: sources of controlled medications in adolescents. J Am Acad Child Adolesc Psychiatry 2019;58:670-80.
Hudgins JD, Porter JJ, Monuteaux MC, Bourgeois FT. Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study. PLoS Med 2019;16:e1002922.
National Institute on Drug Abuse (NIDA). Misuse of prescription drugs: overview [homepage on the Internet]. Bethesda: NIDA; 2024 [cited 2024 Aug 22]. Available from: https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/overview.
Drazdowski TK, Schulte M, Wolitzky-Taylor KB, Schaper H, Chapman JE. Motivations for prescription drug misuse related to mental health problems in adults. Subst Use Misuse 2022; 57:316-27.
McCabe SE, Veliz P, Wilens TE, Boyd J, Schepis S. Sources of nonmedical prescription drug misuse among US high school seniors: Differences in motives and substance use behaviors. J Am Acad Child Adolesc Psychiatry 2019;58:681-91.
Chan WL, Wood DM, Dargan PI. Prescription medicine misuse in the Asia-Pacific region: An evolving issue?. Br J Clin Pharmacol 2021;87:1660-7.
Siste K, Nugraheni P, Christian H, Suryani E, Firdaus KK. Prescription drug misuse in adolescents and young adults: An emerging issue as a health problem. Curr Opin Psychiatry 2019;32:320-7.
Hawangchu D, Rene Lamy F, Stephan Felix M, Phukao D. Transition from nonmedical prescribed opioids to non-injection heroin use among young integrated Thai male users in Bangkok. J Ethn Subst Abuse 2024;23:737-63.
Bonar EE, Coughlin L, Roche JS, Goldstick B, Walton S, Cunningham R. Prescription opioid misuse among adolescents and emerging adults in the United States: a scoping review. Prev Med 2020;132:105972.
National Institute on Drug Abuse (NIDA). Drug misuse and addiction [homepage on the Internet]. Bethesda: NIDA; 2024 [cited 2024 August 25]. Available from: https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/drug-misuse-addiction.
Bhatia D, Mikulich-Gilbertson SK, Sakai JT. Prescription opioid misuse and risky adolescent behavior. Pediatrics 2020;145:e20192470.
Ford JA, McCabe SE, Schepis TS. Prescription drug misuse with alcohol coingestion among US adolescents: youth experiences, health-related factors, and other substance use behaviors. J Addict Med 2023;17:379-86.
Schwartz NE. Nutritional knowledge, attitudes, and practices of high school graduates. J Am Diet Assoc 1975;66:28-31.
Kearney M, Reynolds L, Blitzstein S, Chapin K, Massey P. Primary prevention of prescription drug misuse among culturally and linguistically diverse suburban communities. J Community Health 2019;44:238-48.
Al Rawwad T, Tata V, Wanat MA, Campbell D, Thornton D. Evaluating the feasibility of implementing a prescription drug misuse prevention intervention in the community: a mixed methods study. BMC Public Health 2023;23:728.
Abraham O, Thakur T, Brown R. Prescription opioid misuse and the need to promote medication safety among adolescents. Res Social Adm Pharm 2019;15:841-4.
Grecu AM, Dave DM, Saffer H. Mandatory access prescription drug monitoring programs and prescription drug abuse. J Policy Anal Manage 2019;38:181-209.
Cochran G, Chen Q, Field C, Seybert AL, Hruschak V, Jaber A, et al. A community pharmacy-led intervention for opioid medication misuse: A small-scale randomized clinical trial. Drug Alcohol Depend 2019;205:107570.
Schäfer WLA, Johnson JK, Wafford QE, Plummer SG, Stulberg JJ. Primary prevention of prescription opioid diversion: a systematic review of medication disposal interventions. Am J Drug Alcohol Abuse 2021;47:548-58.
Kenney A, Cox N, Bryan MA, Cochran G. Brief intervention medication therapy management: establishment of an opioid misuse intervention model delivered in a community pharmacy. Am J Health Syst Pharm 2021;78:310-9.
Iloabuchi C, Aboaziza E, Zhao X, Thornton JD, Dwibedi N. College students’ perceptions about prescription drug misuse among peers. Am Health Drug Benefits 2021;14:29-38.
Lucas G, Neeper M, Linde B, Bennett J. Preventing prescription drug misuse in work settings: efficacy of a brief intervention in health consciousness. J Med Internet Res 2017;19:e242.
Bloom BS. Taxonomy of educational objectives, handbook: the cognitive domain. New York: David McKay; 1956.
Best JW. Research in Education. New Jersey: Prentice Hall Inc; 1977.
Nawi AM, Ismail R, Ibrahim F. Risk and protective factors of drug abuse among adolescents: a systematic review. BMC Public Health 2021;21:2088.
Jalali MS, Botticelli M, Hwang RC, Koh HK, McHugh RK. The opioid crisis: a contextual, social-ecological framework. Health Res Policy Syst 2020;18:87.
Wood DM, Dargan PI. Regional, national and international datasets: How they improve our understanding of the acute harms associated with prescription medicine misuse. Br J Clin Pharmacol 2021;87:1654-9.
Evans R, Widman L, Javidi H. Preliminary evaluation of a prescription opioid misuse prevention program among rural middle school students. J Community Health 2020;45:1139-48.
Onuorah S, Agbaje O, Ene O, Ugwueze F. Effects of a school-based substance use prevention education on psychoactive substance knowledge, attitudes and behaviors among young people. Health Educ J 2024;83:664-80.
Chen Q, Larochelle MR, Weaver DT, Lietz AP, Mueller PP, Mercaldo S, et al. Prevention of prescription opioid misuse and projected overdose deaths in the United States. JAMA Network Open 2019;2:e187621.
Carmona J, Maxwell JC, Park JY, Wu LT. Prevalence and health characteristics of prescription opioid use, misuse, and use disorders among U.S. adolescents. J Adolesc Health 2020;66:536-44.
Ford JA. Prescription opioid misuse among adolescents. Pediatr Clin North Am 2019;66:1099-1108.
Agaku I, Odani S, Nelson J. Medical use and misuse of psychoactive prescription medications among US youth and young adults. Fam Med Community Health 2021;9:e000374.
Nkouonlack C, Shifu IN, Atchou JGB. Prevalence and associated factors of non-medical use of prescription drugs among adolescents in secondary schools in Buea, Cameroon: a cross-sectional study. BMC Psychiatry 2023;23:695.
Jones CM, Clayton HB, Deputy NP. Prescription opioid misuse and use of alcohol and other substances among high school students—Youth Risk Behavior Survey, United States, 2019. MMWR Suppl 2020;69:38-46.
Fadaei MH, Farokhzadian J, Miri S, Goojani R. Promoting drug abuse preventive behaviors in adolescent students based on the health belief model. Int J Adolesc Med Health 2020;34:10.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.